Background
==========

Changes observed in modern society in the last decades have led to increasing prevalence of childhood obesity in developed and developing countries \[[@B1]\]. Pediatric obesity is associated with a large variety of metabolic/hemodynamic comorbidities, such as the metabolic syndrome (MS) and non-alcoholic fat liver disease (NAFLD) \[[@B2],[@B3]\].

Deeper analysis have shown that, not only the total, but the distribution of excessive adipose tissue seems to determine the development of these comorbidities and, therefore, abdominal obesity (intra-abdominal adipose tissue \[IAAT\]) is point out as more harmful to human health than subcutaneous adipose tissue (SCAT) \[[@B4],[@B5]\].

It is well documented that adulthood health is affected by risk factors which may determine cardiovascular diseases, such as dyslipidaemia, diabetes type II and hypertension at early age \[[@B6]-[@B8]\] and is fundamental to detect these potential risk factors to prevent or treat obesity. On the other hand, it is not clear whether the above mentioned influence of body fat distribution occur among obese children and adolescents, due to the lack of research about the relationship between IAAT and SCAT with MS and NAFLD in these populations.

The purpose of the present study is to analyze the relationship of NAFLD and components of MS with values of IAAT and SCAT, in a sample of sedentary obese children and adolescents.

Methods
=======

Participants and setting
------------------------

The present study included 182 children and adolescents of both genders (51.6% females), who met the inclusion criteria: (a) obesity identified by body mass index (BMI) according to Cole *et al*. (2000) \[[@B9]\], (b) aged between 6 and 16 years (at evaluation date) and (c) no regular physical activity practice in the last three months prior to the assessment and no disease or limitation that does not allowed the practice (d) sign a written informed consent form for the participation in the study (participants and parents/guardians).

The number of participants at each age ranged from 20 (6 and 7 years), 44 (8 and 9 years), 51 (10 to 12 years) 48 (13 and 14 years) and 19 (15 and 16 years).

The ethical committee of the FCT/UNESP approved this study (Protocol number 07/2009).

Anthropometry
-------------

Body weight (BW) was measured with an electronic scale (precision 0.1 kg \[Filizzola PL 150, Filizzola® Ltda\]) and the height with a wall-mounted stadiometer (precision 0.1 cm \[Sanny®, São Paulo, Brazil\]), with the subjects wearing light clothing and no shoes. Anthropometric measurements were performed by trained researchers, according to standardized techniques \[[@B10]\].

Dual energy X-ray absorptiometry
--------------------------------

Percentage of body fat (%BF) and amount of trunk fat mass (TFM \[kg\]) were estimated by a Dual-energy X-ray absorptiometry- DXA scanner (Lunar DPX-NT; General Electric Healthcare, Little Chalfont, Buckinghamshire \[software version 4.7\]). The measurement took approximately 15 minutes and the subjects remained in a supine position during the scanning, wearing light clothing while lying flat on their back with arms by the side, without moving during the measurement. The results were transmitted to a connected computer for further analysis, according to the manufacturer orientation.

All Dual-energy X-ray absorptiometry- DXA measurements were made at the laboratory of the São Paulo State University Campus of Presidente Prudente, in a room with controlled temperature. Each morning before beginning the measurements, the equipment was calibrated by the same researcher and, according to the references provided by the manufacturer.

Pubertal stages
---------------

Pubertal stage was self-assessed by the participants aged older than 10 years. A standardized series of drawings was given to the subjects to assess their own pubertal development according to Tanner, *et al.* (1969, 1970) \[[@B11],[@B12]\]. Girls received drawings with the five pubertal stages of Tanner with breast and female pubic hair development, with appropriate descriptions. Boys received drawings with the five pubertal stages of Tanner with male genitalia and pubic hair development, with appropriate descriptions. It was asked to the subjects to select the drawing stage that best indicated his/her own development. The results were placed in a locked box by each subject to guarantee the integrity and anonymity of the subjects. The five stages of Tanner of pubic hair development were grouped in three classifications: Group 1 = subjects aged under 10 years and those who answered stage 1; Group 2 = subjects who answered stages 2 and 3; Group 3 = Subjects who answered stages 4 and 5.

Blood samples
-------------

After a 12 hour fasting, blood samples were collected, by nurses, on tubes containing EDTA, an anticoagulant for blood samples. All blood samples were analysed in a private laboratory. Triglycerides, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin and glucose were analysed, using the colorimetric method (dyslipidemia was identified as any modification in the lipid variables). The dosage of insulin was performed using the Elisa Kit (RayBio® Human Insulin ELISA Kit), according to the manufacturer instructions.

Blood pressure
--------------

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were measured with an electronic device (MX3Plus; Omron Corporation, Kyoto, Kansai, Japan), previously validated for pediatric populations \[[@B13]\]. The measurements were taken after 15 minutes of rest in a sitting position. Two measures were taken on the right arm, with a 2-minute interval between them and mean value of both measures was used. Two types of cuffs were used according to arm circumference. The classification of elevated blood pressure (EBP) was made by 95^th^ centile or higher for age, gender and height, according to National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (NHBPEP, 2004) \[[@B14]\].

Metabolic syndrome
------------------

The presence of MS was identified according to the cut offs proposed by World Health Organization adapted for children and adolescents \[[@B15]\]. The diagnosis of MS was based in the presence of, at least, three criteria. 1) Obesity: BMI ≥ 95th centile; 2) Glucose homeostasis: defined by hyperinsulinemia according to the norms for pubertal stage: pre-pubertal ≥15 mU/L, mid-puberty (stages 2--3) ≥ 30 mU/L \[[@B16]\], and post-pubertal ≥20 mU/L (adult value) and/or fasting glucose ≥ 110 mg/dL; 3) Hypertension: systolic blood pressure (SBP) ≥ 95th centile for age, gender and height \[[@B14]\]; 4) Dyslipidaemia: triglycerides \>155 mg/dL, high density lipoprotein (HDL) \< 35 mg/dL and total cholesterol ≥ 95th centile. Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated according to the formula proposed by Matthews *et al*. (1985) \[[@B17]\]: HOMA-IR = Fasting insulin (mU/mL) X fasting glucose (mgl/dL)/405.

Ultrasound
----------

An ultrasound equipment (Toshiba Aplio Model Tochigi-ken, Japan) was used to assess the fat accumulation and the morphology of the liver (size of the left and right lobes), by a specialist medical doctor. NAFLD was stratified as followed: absent (0), mild (level 1), moderate (level 2) and severe (level 3). However, the sample was dichotomized: Absence and Presence, because of the lack of subjects with severe level. The ultrasound also measured intra-abdominal (IAAT) and subcutaneous (SCAT) abdominal adipose tissue thickness (cm). The values of IAAT and SCAT were stratified into quartile (Quartile~1~; Quartile~2-3~; Quartile~4~).

Statistical analysis
--------------------

Numerical variables were presented as mean and standard deviation. Test-T was used for comparison of the general variables between sexes. Chi-square test compared the categorical variables. Binary logistic regression (odds ratio \[OR\] and 95% confidence interval \[OR~95%CI~\]) indicated the magnitude of the associations adjusted by potential confounders (sex, age, maturation, classification of NAFLD and HOMA-IR). Statistical significance was set at 5% and the Statistical Package for Social Science, version 17.0 (SPSS Inc, Chicago, Illinois) was used for all analyses.

Results
=======

The comparison between male and female subjects (Table [1](#T1){ref-type="table"}), showed similarity for age (p = 0.994), all biochemical variables, including, insulin resistance (p = 0.356) and dyslipidemia (p = 0.391) and blood pressure at rest (SBP with p = 0.426 and DBP with p = 0.551) and elevated (p = 0.740). The prevalence of MS was high in both genders (male 52.3% and female: 42.6%; p = 0.381). Boys presented lower percentage of body fatness (p = 0.012), however, higher IAAT than girls (p = 0.001).

###### 

General characteristics of obese youth stratified by sex (n = 182)

                             **Total (n = 182)**   **Male (n = 88)**   **Female (n = 94)**   **P**
  ------------------------- --------------------- ------------------- --------------------- -------
                                  Mean (SD)            Mean (SD)            Mean (SD)           
  Age (years)                    11.0 (2.7)           11.1 (2.8)           11.1 (2.7)        0.994
  Fasting glucose (mg/dL)        82.0 (7.1)           82.7 (7.2)           81.1 (6.9)        0.126
  Triglycerides (mg/dL)         115.11 (51.3)        117.7 (58.5)         112.6 (43.7)       0.507
  Cholesterol (mg/dL)           163.5 (32.9)         164.8 (36.3)         162.3 (29.4)       0.601
  HDL-C (mg/dL)                  43.1 (9.9)           42.9 (10.4)          43.3 (9.4)        0.771
  LDL-C (mg/dL)                  97.4 (28.9)          98.4 (31.8)          96.4 (25.9)       0.641
  IAAT (cm)                       4.4 (1.6)           4.81 (1.65)          3.97 (1.34)       0.001
  SCAT (cm)                       3.3 (1.4)           3.34 (1.55)          3.22 (1.28)       0.550
  %BF                            46.1 (5.4)           44.6 (5.5)           46.6 (4.8)        0.012
  TrunkBF (kg)                   17.9 (6.9)           15.2 (7.1)           14.3 (7.8)        0.440
  SBP (mmHg)                    116.3 (19.6)         117.5 (22.4)         115.2 (16.5)       0.426
  DBP (mmHg)                     69.0 (11.9)          68.4 (13.4)          69.5 (10.2)       0.551
  NAFLD (%)                         26.4                 36,4                 17.0           0.005
  MS components (%)                                                                             
  Hyperinsulinemia                  65.4                 69.3                 61.7           0.356
  EBP                               35.7                 37.5                  34            0.740
  Dyslipidemia                      46.2                  50                  42.6           0.391
  MS                                48.4                 52.3                 44.7           0.381

*SD* standard-deviation, *HDL-C* high density lipoprotein cholesterol, *LDL-C* low density lipoprotein cholesterol, *SBP* systolic blood pressure; *DBP* diastolic blood pressure, *IAAT* intra-abdominal adipose tissue, *SCAT* subcutaneous adipose tissue, *%BF* percentage of body fatness, *EBP* elevated blood pressure, *MS* metabolic syndrome, *NAFLD* non-alcoholic fat liver disease.

Higher quartile of SCAT was associated with EBP (chi-square with p = 0.015 (Table [2](#T2){ref-type="table"}), but not with NAFLD (p = 0.665). However, IAAT was positively associated with increased occurrence of dyslipidemia (p = 0.001), MS (p = 0.013) and NAFLD (p = 0.005). Hyperinsulinemia was not associated with SCAT and IAAT. The classification of NAFLD was positively associated with insulin resistance (Table [3](#T3){ref-type="table"}), and marginally associated with MS (p = 0.075).

###### 

Association between abdominal adipose tissue, non-alcoholic fatty liver disease and metabolic syndrome in obese youth (n = 182)

                        **Subcutaneous abdominal adipose tissue (Quartile)**    **P**           
  -------------------- ------------------------------------------------------ --------- ------- -------
    Hyperinsulinemia                           66.7%                            63.3%     68%    0.866
    EBP                                        28.6%                             30%      52%    0.015
    Dyslipidemia                                50%                             51.1%     34%    0.108
    MS                                         45.2%                            45.6%     56%    0.285
    NAFLD                                      21.4%                            28.9%     26%    0.665
                             Intra-abdominal adipose tissue (Quartile)            P             
  MS components                                \<P25                           P25-P75   ≥P75   
    Hyperinsulinemia                           58.5%                            66.3%    69.6%   0.287
    EBP                                        31.7%                            32.6%    45.7%   0.165
    Dyslipidemia                                22%                             49.5%    60.9%   0.001
    MS                                         34.1%                            48.4%    60.9%   0.013
   NAFLD                                       14.6%                            24.2%    41.3%   0.005

*P*25 25^th^ percentile; *P*75 = 75^th^ percentile, *EBP* elevated blood pressure, *MS* metabolic syndrome, *NAFLD* non-alcoholic fat liver disease.

###### 

Association between non-alcoholic fatty liver disease and metabolic syndrome components in obese children and adolescents (n = 182)

                        **Non-alcoholic fatty liver disease**   **P**  
  -------------------- --------------------------------------- ------- -------
    Hyperinsulinemia                    60.4%                   79.2%   0.031
    EBP                                 35.1%                   37.5%   0.900
    Dyslipidemia                        42.5%                   56.3%   0.143
  MS                                     44%                    60.4%   0.075

*EBP* elevated blood pressure, *MS* metabolic syndrome.

In the multivariate model, statistically significant associations in the chi-square test were analyzed under adjustment of potential confounders (sex, age, maturation, presence of NAFLD and HOMA-IR). The association between higher quartile of SCAT and EBP did not reach statistical significance, in both adjusted models (Model 1- OR = 1.86 \[0.70 -- 4.91\]; p = 0.210; Model 2- OR = 1.90 \[0.71 -- 5.05\]; p = 0.195). On the other hand, both intermediate (OR = 3.33 \[1.39 -- 8.00\]; p = 0.007) and highest (OR = 5.23 \[1.92 -- 14.2\]; p = 0.001) quartile of IAAT were significantly associated to dyslipidemia, independently of age, sex, maturation, NAFLD and HOMA-IR (Table [4](#T4){ref-type="table"}).

###### 

Multivariate model for association between abdominal adipose tissue and metabolic syndrome components (n = 182)

  **Abdominal adipose tissue**   **Binary logistic regression**    **Binary logistic regression**   **Binary logistic regression**                                                      
  ------------------------------ -------------------------------- -------------------------------- -------------------------------- --------------------- ------- --------------------- -------
                                 SCAT                                      OR (OR~95%CI~)                         p                    OR (OR~95%CI~)        p       OR (OR~95%CI~)        p
  EBP                              \<P25                                        1.00                            \-\--                       1.00           \-\--          1.00           \-\--
                                   P25-75                               1.07 (0.47 -- 2.41)                     0.867                0.89 (0.38 -- 2.07)   0.795   0.88 (0.38 -- 2.05)   0.776
                                   ≥P75                                 2.71 (1.13 -- 6.46)                     0.025                1.86 (0.70 -- 4.91)   0.210   1.90 (0.71 -- 5.05)   0.195
                                 IAAT                                      OR (OR~95%CI~)                         p                    OR (OR~95%CI~)        p       OR (OR~95%CI~)        p
  Dyslipidemia                     \<P25                                        1.00                            \-\--                       1.00           \-\--          1.00           \-\--
                                   P25-75                               3.48 (1.50 -- 8.07)                     0.004                3.48 (1.46 -- 8.31)   0.005   3.33 (1.39 -- 8.00)   0.007
                                   ≥P75                                 5.53 (2.14 -- 14.2)                     0.001                5.65 (2.09 -- 15.2)   0.001   5.23 (1.92 -- 14.2)   0.001

Model-1: crude analysis; Model-2: analysis adjusted by sex, age and maturation; Model-3: analysis adjusted by sex, age, maturation, NAFLD and HOMA-IR; *EBP* elevated blood pressure, *NAFLD* non-alcoholic fat liver disease, *OR* odds ratio, *95% CI* 95% confidence interval, *IAAT* intra-abdominal adipose tissue, *SCAT* subcutaneous adipose tissue, *EBP* elevated blood pressure, *MS* metabolic syndrome.

Discussion
==========

Despite seeming higher in obese youth, MS prevalence is not clear, because there is not yet a standard reference table worldwide accepted \[[@B18]\]. In our obese sample, boys (52.3%) and girls (44.7%) presented higher prevalence of the outcome than in another study with obese Brazilian adolescents (27,6%) \[[@B19]\] that used the same classification for MS. Moreover, the prevalence of NAFLD in our obese sample (26.4%) was similar to those recently observed in other overweight/obese adolescents (27,7%) \[[@B20]\]. Therefore, MS and NAFLD should be a relevant concern in developing countries, which experienced rapid industrialization process during the last decades, but without a consistent health politics related to nutrition and promotion of physical activity.

NAFLD was significantly associated with increased fasting insulin and glucose and marginally with MS. Previously, Ayonrinde *et al*. (2011) \[[@B21]\] identified in 1170 Australian adolescents that fat accumulation in the liver is related to decreased values of insulin. Other components of MS presented similar result of association with NAFLD, which is in accordance with previous studies, that refers to NAFLD as the "hepatic manifestation" of the MS \[[@B22]\].

Regarding the association between IAAT and dyslipidemia, the scientific literature has offered support to the idea that insulin resistance plays key role in the genesis of the NAFLD and components of MS \[[@B4]\], mainly in cases when the abdominal obesity is present. Adipose tissue has an endocrine function that produces multiple adipokines causing inflammatory process and insulin resistance \[[@B4],[@B23],[@B24]\]. Visceral adipose tissue located at abdominal region has particularities related to higher lipolysis, higher release of adipokines and these characteristics increase its atherosclerotic capacity \[[@B4]\].

Adipokines like tumor necrosis factor-α (TNF-α) and interleukine-6 are largely produced by abdominal fat and have been related to insulin resistance. TNF-α interferes on insulin metabolism cascade, activating proinflammatory pathways that impair insulin signalling at the level of the insulin receptor substrate proteins, causing insulin resistance \[[@B25]\]. Besides, TNF-α inhibits adiponectin expression, causes elevation in serum free fat acid by stimulation of lipolysis and hepatic lipogenesis, contributing for insulin resistance and may lead to development of NAFLD \[[@B4],[@B23],[@B26]\], justifying our findings.

Our results indicated that IAAT was more important than SCAT in the genesis of the MS and NAFLD \[[@B27]\]. Although SCAT has been associated with blood pressure and, in fact, the above mentioned pathways are strongly related to endothelial dysfunction \[[@B4]\], the significance was lost after the adjustments. Various studies have shown that, the increase of free fat acid in circulation corroborates with formation of low density lipoproteins (LDL) e very low density lipoproteins (VLDL) associated to reduction on high density lipoproteins (HDL) and very high density lipoproteins (VHDL), which results in atherosclerosis and elevation of arterial pressure \[[@B28],[@B29]\].

Limitations of the study should be highlighted. The cross-sectional design constitutes a limitation because it is not possible to establish a causality of the involved variables. Moreover, the absence of pro-inflammatory adipokines analysis should be considered in the interpretation of the findings. In addition, the NAFLD was not diagnosed by liver biopsy, which is considered the gold standard, otherwise, the ultrasound is considered a useful tool for initial screening \[[@B30],[@B31]\], based on parameters such as hepatorenal echo contrast and liver echogenicity \[[@B32]\]. Another reason is the unclear perform of serum aminotransferases, such as ALT and AST to diagnosis NAFLD in adults and children \[[@B33]\].

Furthermore, interventional studies are necessary to offer consistent support to our proposed model of analysis.

Conclusions
===========

In summary, our findings identified that, in obese adolescents, intra-abdominal fat seems to be more relevant to the development of MS and NAFLD than subcutaneous fat, and these results are independent of possible confounding variables. However, future studies with larger sample are necessary to confirm this evidence and perhaps, suggest a cut off of visceral fat to predict MS and NAFLD.
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